{
    "id": "606b3b6794d57fd879000064",
    "question": "Is the glucocorticoid receptor a transcription factor?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the functions and characteristics of the glucocorticoid receptor. The glucocorticoid receptor is a protein that plays a crucial role in regulating gene expression in response to glucocorticoids. It acts as a transcription factor by binding to specific DNA sequences in the regulatory regions of target genes, thereby influencing the transcription of these genes. This process involves the recruitment of coactivator proteins and assembly of general transcription factors, leading to increased or decreased transcription of the targeted genes. The glucocorticoid receptor also interacts with other transcription factors and influences their activity, either enhancing or inhibiting their ability to activate gene expression. This complex interplay of interactions allows the glucocorticoid receptor to fine-tune the expression of a wide range of genes, making it a critical component of the glucocorticoid signaling pathway. Based on this understanding, we can conclude that the glucocorticoid receptor indeed acts as a transcription factor.\", \"answer_choice\": \"A\"}",
    "snippets": [
        {
            "id": "Cell_Biology_Alberts_1901",
            "title": "Cell_Biology_Alberts",
            "content": "Figure 7\u201338 A single transcription regulator can coordinate the expression of many different genes. the action of the glucocorticoid receptor is illustrated schematically. On the left is a series of genes, each of which has various transcription regulators bound to its regulatory region. however, these bound proteins are not sufficient on their own to fully activate transcription. On the right is shown the effect of adding an additional transcription regulator\u2014the glucocorticoid receptor in a complex with glucocorticoid hormone\u2014that has a cisregulatory sequence in the control region of each gene. the glucocorticoid receptor completes the combination of transcription regulators required for maximal initiation of transcription, and the genes are now switched on as a set. when the hormone is no longer present, the glucocorticoid receptor dissociates from DnA and the genes return to their pre-stimulated levels."
        },
        {
            "id": "Pharmacology_Katzung_4351",
            "title": "Pharmacology_Katzung",
            "content": "The interaction of glucocorticoid receptors with GREs or other transcription factors is facilitated or inhibited by several families of proteins called steroid receptor coregulators, divided into coactivators and corepressors. The coregulators do this by serving as bridges between the receptors and other nuclear proteins and by expressing enzymatic activities such as histone acetylase or deacetylase, which alter the conformation of nucleosomes and the transcribability of genes. Between 10% and 20% of expressed genes in a cell are regulated by glucocorticoids. The number and affinity of receptors for the hormone, the complement of transcription factors and coregulators, and post-transcription events determine the relative specificity of these hormones\u2019 actions in various cells. The effects of glucocorticoids are mainly due to proteins synthesized from mRNA transcribed from their target genes."
        },
        {
            "id": "Cell_Biology_Alberts_1899",
            "title": "Cell_Biology_Alberts",
            "content": "The effects of the glucocorticoid receptor are not confined to cells of the liver. In other cell types, activation of this transcription regulator by hormone also causes changes in the expression levels of many genes; the genes affected, however, are usually different from those affected in liver cells. As we have seen, each cell type has an individualized set of transcription regulators, and because of combinatorial control, these critically influence the action of the glucocorticoid receptor. Because the receptor is able to assemble with many different sets of celltype-specific transcription regulators, switching it on with hormone produces a different spectrum of effects in each cell type."
        },
        {
            "id": "Pharmacology_Katzung_4347",
            "title": "Pharmacology_Katzung",
            "content": "Two genes for the corticoid receptor have been identified: one encoding the classic glucocorticoid receptor (GR) and the other encoding the mineralocorticoid receptor (MR). Alternative splicing of human glucocorticoid receptor pre-mRNA generates two highly homologous isoforms, termed hGR\u03b1 and hGR\u03b2. Human GR\u03b1 is the classic ligand-activated glucocorticoid receptor, which, in the hormone-bound state, modulates the expression of glucocorticoid-responsive genes. In contrast, hGR\u03b2 does not bind glucocorticoids and is transcriptionally inactive. However, hGR\u03b2 is able to inhibit the effects of hormone-activated hGR\u03b1 on glucocorticoid-responsive genes, playing the role of a physiologically relevant endogenous inhibitor of glucocorticoid action. It was recently shown that the two hGR alternative transcripts have eight distinct translation initiation sites\u2014ie, in a human cell there may be up to 16 GR\u03b1 and GR\u03b2 isoforms, which may form up to 256 homodimers and heterodimers with different"
        },
        {
            "id": "Pharmacology_Katzung_4346",
            "title": "Pharmacology_Katzung",
            "content": "In addition to binding to GREs, the ligand-bound receptor also forms complexes with and influences the function of other transcription factors, such as AP1 and nuclear factor kappa-B (NF-\u03baB), which act on non-GRE-containing promoters, to contribute to the regulation of transcription of their responsive genes. These transcription factors have broad actions on the regulation of growth factors, proinflammatory cytokines, etc, and to a great extent mediate the anti-growth, anti-inflammatory, and immunosuppressive effects of glucocorticoids."
        },
        {
            "id": "Physiology_Levy_4116",
            "title": "Physiology_Levy",
            "content": "Mechanism of Action of Cortisol Cortisol acts primarily through the glucocorticoid receptor, which regulates gene transcription (see ). In the absence of hormone, the GR resides in the cytoplasm in a stable complex with several molecular chaperones, including heat shock proteins and cyclophilins. Cortisol-GR binding promotes dissociation of the chaperone proteins, followed by: aAllvaluesarerelativetotheglucocorticoidandmineralocorticoidpotenciesofcortisol,whichhaveeachbeenarbitrarilysetat1.0.Cortisolactuallyhasonly1/500thepotencyofthenaturalmineralocorticoidaldosterone. 1. rapid translocation of the cortisol-GR complex into the nucleus, 2. dimerization and binding to glucocorticoid response elements (GREs, both \u201cpositive\u201d GREs and \u201cnegative\u201d GREs) near the basal promoters of cortisol-regulated genes, and 3. recruitment of coactivator proteins and assembly of general transcription factors leading to increased or decreased transcription of the targeted genes."
        },
        {
            "id": "Pharmacology_Katzung_184",
            "title": "Pharmacology_Katzung",
            "content": "These \u201cgene-active\u201d receptors belong to a protein family that evolved from a common precursor. Dissection of the receptors by recombinant DNA techniques has provided insights into their molecular mechanism. For example, binding of glucocorticoid hormone to its normal receptor protein relieves an inhibitory constraint on the transcription-stimulating activity of the protein. Figure 2\u20136 schematically depicts the molecular mechanism of glucocorticoid action: In the absence of hormone, the receptor is bound to hsp90, a protein that prevents normal folding of several structural domains of the receptor. Binding of hormone to the ligand-binding domain triggers release of hsp90. This allows the DNA-binding and transcription-activating domains of the receptor to fold into their functionally active conformations, so that the activated receptor can initiate transcription of target genes."
        },
        {
            "id": "Cell_Biology_Alberts_1897",
            "title": "Cell_Biology_Alberts",
            "content": "An example is the rapid control of gene expression by the human glucocorticoid receptor protein. To bind to its cis-regulatory sequences in the genome, this transcription regulator must first form a complex with a molecule of a glucocorticoid steroid hormone, such as cortisol (see Figure 15\u201364). The body releases this hormone during times of starvation and intense physical activity, and among its other activities, it stimulates liver cells to increase the production of glucose from amino acids and other small molecules. To respond in this way, liver cells increase the expression of many different genes that code for metabolic enzymes, such as tyrosine aminotransferase, as we discussed earlier in this chapter (see Figure 7\u20133). Although these genes all have different and complex control regions, their maximal expression depends on the binding of the hormone\u2013glucocorticoid receptor complex to its cis-regulatory sequence, which is present in the control region of each gene. When the body"
        },
        {
            "id": "Pharmacology_Katzung_4344",
            "title": "Pharmacology_Katzung",
            "content": "Most of the known effects of the glucocorticoids are mediated by widely distributed intracellular glucocorticoid receptors. These proteins are members of the superfamily of nuclear receptors, which includes steroid, sterol (vitamin D), thyroid, retinoic acid, and many other receptors with unknown or nonexistent ligands (orphan receptors). All these receptors interact with the promoters of\u2014and regulate the transcription of\u2014target genes (Figure 39\u20134). In the absence of the hormonal ligand, glucocorticoid receptors are primarily cytoplasmic, in oligomeric complexes with chaperone heat-shock proteins (hsp). The most important of these are two molecules of hsp90, although other proteins (eg, hsp40, hsp70, FKBP5) are also involved. Free hormone from the plasma and interstitial fluid enters the cell and binds to the receptor, inducing conformational changes that allow it to dissociate from the heat shock proteins and dimerize. The dimeric ligand-bound receptor complex then is actively"
        },
        {
            "id": "Pharmacology_Katzung_4355",
            "title": "Pharmacology_Katzung",
            "content": "FIGURE 39\u20134 A model of the interaction of a steroid, S (eg, cortisol), and its receptor, R, and the subsequent events in a target cell. The steroid is present in the blood in bound form on the corticosteroid-binding globulin (CBG) but enters the cell as the free molecule. The intracellular receptor is bound to stabilizing proteins, including two molecules of heat-shock protein 90 (hsp90) and several others including FKBP5, denoted as \u201cX\u201d in the figure. This receptor complex is incapable of activating transcription. When the complex binds a molecule of cortisol, an unstable complex is created and the hsp90 and associated molecules are released. The steroid-receptor complex is now able to dimerize, enter the nucleus, bind to a glucocorticoid response element (GRE) on the regulatory region of the gene, and regulate transcription by RNA polymerase II and associated transcription factors. A variety of regulatory factors (not shown) may participate in facilitating (coactivators) or"
        },
        {
            "id": "Cell_Biology_Alberts_1898",
            "title": "Cell_Biology_Alberts",
            "content": "their maximal expression depends on the binding of the hormone\u2013glucocorticoid receptor complex to its cis-regulatory sequence, which is present in the control region of each gene. When the body has recovered and the hormone is no longer present, the expression of each of these genes drops to its normal level in the liver. In this way, a single transcription regulator can rapidly control the expression of many different genes (Figure 7\u201338)."
        },
        {
            "id": "Physiology_Levy_268",
            "title": "Physiology_Levy",
            "content": "When activated by hormone binding, nuclear receptors bind to specific DNA sequences in the regulatory regions of responsive genes called hormone response elements. Ligand-receptor binding to DNA causes a conformational change in DNA that initiates transcription. Nuclear receptors also regulate gene expression by acting as transcriptional repressors. For example, glucocorticoids suppress the transcription activator protein-1 (AP-1) and nuclear factor \u03baB, which stimulate the expression of genes that cause inflammation. By this mechanism glucocorticoids reduce inflammation. As noted previously, cAMP is an important second messenger. In addition to its importance in activating PKA, which phosphorylates specific serine and threonine residues on proteins, cAMP stimulates the transcription of many genes, including those that code for hormones, including somatostatin, glucagon, and vasoactive intestinal polypeptide (see"
        },
        {
            "id": "InternalMed_Harrison_26347",
            "title": "InternalMed_Harrison",
            "content": "The family of nuclear receptors has grown to nearly 100 members, many of which are still classified as orphan receptors because their ligands, if they exist, have not been identified (Fig. 400e-2). Otherwise, most nuclear receptors are classified on the basis of their ligands. Although all nuclear receptors ultimately act to increase or decrease gene transcription, some (e.g., glucocorticoid receptor) reside primarily in the cytoplasm, whereas others (e.g., TR) are located in the nucleus. After ligand binding, the cytoplasmically localized receptors translocate to the nucleus. There is growing evidence that certain nuclear receptors (e.g., glucocorticoid, estrogen) can also act at the membrane or in the cytoplasm to activate or repress signal transduction pathways, providing a mechanism for cross-talk between membrane and nuclear receptors."
        },
        {
            "id": "Pharmacology_Katzung_186",
            "title": "Pharmacology_Katzung",
            "content": "This class of receptor molecules mediates the first steps in signaling by insulin, epidermal growth factor (EGF), platelet-derived growth factor (PDGF), atrial natriuretic peptide (ANP), transforming growth factor-\u03b2 (TGF-\u03b2), and many other trophic hormones. These receptors are polypeptides consisting of an extracellular Altered transcription of specific genes FIGURE 2\u20136 Mechanism of glucocorticoid action. The glucocorticoid receptor polypeptide is schematically depicted as a protein with three distinct domains. A heat-shock protein, hsp90, binds to the receptor in the absence of hormone and prevents folding into the active conformation of the receptor. Binding of a hormone ligand (steroid) causes dissociation of the hsp90 stabilizer and permits conversion to the active configuration."
        },
        {
            "id": "Pharmacology_Katzung_4353",
            "title": "Pharmacology_Katzung",
            "content": "The GR also interacts with other regulators of cell function. One such molecule is CLOCK/BMAL-1, a transcription factor dimer expressed in all tissues and generating the circadian rhythm of cortisol secretion (Figure 39\u20132) at the suprachiasmatic nucleus of the hypothalamus. CLOCK is an acetyltransferase that acetylates the hinge region of the GR, neutralizing its transcriptional activity and thus rendering target tissues resistant to glucocorticoids. As shown in Figure 39\u20132, lower panel, the glucocorticoid target tissue sensitivity rhythm generated is in reverse phase to that of circulating cortisol concentrations, explaining the increased sensitivity of the organism to evening administration of glucocorticoids. The GR also interacts with NF-\u03baB, a regulator of production of cytokines and other molecules involved in inflammation."
        },
        {
            "id": "Pharmacology_Katzung_4437",
            "title": "Pharmacology_Katzung",
            "content": "Bamberger CM, Schulte HM, Chrousos GP: Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 1996;17:245. Charmandari E et al: Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man. PLoS One 2011;6:e25612. Charmandari E, Kino T: Chrousos syndrome: A seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signaling changes. Eur J Clin Invest 2010;40:932. Charmandari E, Nicolaides NC, Chrousos GP: Adrenal insufficiency. Lancet. 2014;383:2152. Charmandari E, Tsigos C, Chrousos GP: Neuroendocrinology of stress. Ann Rev Physiol 2005;67:259. Chrousos GP: Stress and disorders of the stress system. Nat Rev Endocrinol 2009;5:374."
        },
        {
            "id": "InternalMed_Harrison_26949",
            "title": "InternalMed_Harrison",
            "content": "proteins (HSP) from the receptor and subsequent dimerization (Fig. 406-6). Cortisol-bound GR dimers translocate to the nucleus and activate glucocorticoid response elements (GRE) in the DNA sequence, thereby enhancing transcription of glucocorticoid-regulated genes (GR transactivation). However, cortisol-bound GR can also form heterodimers with transcription factors such as AP-1 or NF-\u03baB, resulting in transrepression of proinflammatory genes, a mechanism of major importance for the anti-inflammatory action of glucocorticoids. It is important to note that corticosterone also exerts glucocorticoid activity, albeit much weaker than cortisol itself. However, in rodents, corticosterone is the major glucocorticoid, and in patients with 17-hydroxylase deficiency, lack of cortisol can be compensated for by higher concentrations of corticosterone that accumulates as a consequence of the enzymatic block."
        },
        {
            "id": "Pharmacology_Katzung_4429",
            "title": "Pharmacology_Katzung",
            "content": "interaction of the glucocorticoid receptor with coregulators, favoring the formation of a transcriptionally inactive complex in the cell nucleus. The result is inhibition of glucocorticoid receptor activation."
        },
        {
            "id": "Biochemistry_Lippincott_1647",
            "title": "Biochemistry_Lippinco",
            "content": "Intracellular receptors: Members of the nuclear receptor superfamily, which includes the steroid hormone (glucocorticoids, mineralocorticoids, androgens, and estrogens), vitamin D, retinoic acid, and thyroid hormone receptors, function as STF. In addition to domains for DNA-binding and transcriptional activation, these receptors also contain a ligand-binding domain. For example, the steroid hormone cortisol (a glucocorticoid) binds intracellular receptors at the ligand-binding domain (Fig. 33.10). Binding causes a conformational change in the receptor that activates it. The receptor\u2013 hormone complex enters the nucleus, dimerizes, and binds via a zinc finger motif to DNA at a regulatory element, the glucocorticoid response element (GRE) that is an example of a HRE. Binding allows recruitment of coactivators to the TAD and results in expression of cortisol-responsive genes, each of which is under the control of its own GRE. Binding of the receptor\u2013hormone complex to the GRE allows"
        },
        {
            "id": "InternalMed_Harrison_26352",
            "title": "InternalMed_Harrison",
            "content": "The functions of individual hormones are described in detail in subsequent chapters. Nevertheless, it is useful to illustrate how most biologic responses require integration of several different hormone pathways. The physiologic functions of hormones can be divided into three general areas: (1) growth and differentiation, (2) maintenance of homeostasis, and (3) reproduction. FIGURE 400e-2 Nuclear receptor signaling. AR, androgen receptor; DAX, dosage-sensitive sex-reversal, adrenal hypoplasia congenita, X-chromosome; ER, estrogen receptor; GR, glucocorticoid receptor; HNF4\u03b1, hepatic nuclear factor 4\u03b1; PPAR, peroxisome proliferator activated receptor; PR, progesterone receptor; RAR, retinoic acid receptor; SF-1, steroidogenic factor-1; TR, thyroid hormone receptor; VDR, vitamin D receptor."
        },
        {
            "id": "Immunology_Janeway_4010",
            "title": "Immunology_Janeway",
            "content": "Treatment of unwanted immune responses. membrane and bind to intracellular receptors of the nuclear receptor family. Activated glucocorticoid receptors are transported to the nucleus, where they bind directly to DNA and interact with other transcription factors to regulate as many as 20% of the genes expressed in leukocytes. The response to steroid therapy is complex, given the large number of genes regulated in leukocytes and in other tissues. With respect to immunosuppression, corticosteroids exert multiple anti-inflammatory effects, which are briefly summarized in Fig. 16.3."
        },
        {
            "id": "Pharmacology_Katzung_4350",
            "title": "Pharmacology_Katzung",
            "content": "The prototype GR isoform is composed of about 800 amino acids and can be divided into three functional domains (see Figure 2\u20136). The glucocorticoid-binding domain is located at the carboxyl terminal of the molecule. The DNA-binding domain is located in the middle of the protein and contains nine cysteine residues. This region folds into a \u201ctwo-finger\u201d structure stabilized by zinc ions connected to cysteines to form two tetrahedrons. This part of the molecule binds to the GREs that regulate glucocorticoid action on glucocorticoidregulated genes. The zinc fingers represent the basic structure by which the DNA-binding domain recognizes specific nucleic acid sequences. The amino-terminal domain is involved in the transactivation activity of the receptor and increases its specificity."
        },
        {
            "id": "InternalMed_Harrison_27313",
            "title": "InternalMed_Harrison",
            "content": "The androgen receptor (AR) is structurally related to the nuclear receptors for estrogen, glucocorticoids, and progesterone (Chap. 400e). The AR is encoded by a gene on the long arm of the X chromosome and has a molecular mass of about 110 kDa. A polymorphic region in the amino terminus of the receptor, which contains a variable number of glutamine repeats, modifies the transcriptional activity of the receptor. The AR protein is distributed in both the cytoplasm and the nucleus. The ligand binding to the AR induces con formational changes that allow the recruitment and assembly of tissue-specific cofactors and causes it to translocate into the nucleus, where it binds to DNA or other transcription factors already bound to DNA. Thus, the AR is a ligand-regulated transcription factor that regulates the expression of androgen-dependent genes in a tissue-specific manner. Some androgen effects may be mediated by nongenomic AR signal transduction pathways. Testosterone binds to AR with half"
        },
        {
            "id": "Physiology_Levy_3747",
            "title": "Physiology_Levy",
            "content": "and the receptors to which they bind. For example, glucocorticoids bind to the mineralocorticoid receptor with high affinity, and progestins, glucocorticoids, and androgens can all interact with the progesterone, glucocorticoid, and androgen receptors to some degree. As discussed later, steroid hormones are hydrophobic and pass through cell membranes easily. Accordingly, classic steroid hormone receptors are localized intracellularly and act by regulating gene expression. There is mounting evidence of the presence of plasma membrane and juxtamembrane steroid hormone receptors that mediate rapid, nongenomic actions of steroid hormones."
        },
        {
            "id": "Pharmacology_Katzung_4340",
            "title": "Pharmacology_Katzung",
            "content": "FIGURE 39\u20132 Circadian variation in plasma cortisol throughout the 24-hour day (upper panel). The sensitivity of tissues to glucocorticoids is also circadian but inverse to that of cortisol, with low sensitivity in the late morning and high sensitivity in the evening and early night (lower panel). The sensitivity of tissues to glucocorticoids is inversely related to that of glucocorticoid receptor (GR) acetylation by the transcription factor CLOCK; the acetylated receptor has decreased transcriptional activity. (Adapted, with permission, from Nader N, Chrousos GP, Kino T: Interactions of the circadian CLOCK system and the HPA axis. Trends Endocrinol Metab 2010;21:277. Copyright Elsevier.) 5\u201310%) or loosely bound to albumin (about 5%) and is available to exert its effect on target cells. When plasma cortisol levels exceed 20\u201330 mcg/dL, CBG is saturated, and the concentration of free cortisol rises rapidly. CBG is increased in pregnancy, with estrogen administration, and in"
        },
        {
            "id": "Pharmacology_Katzung_3260",
            "title": "Pharmacology_Katzung",
            "content": "Integration of Hypotheses Regarding the Pathophysiology of Depression The several pathophysiologic hypotheses just described are not mutually exclusive. It is evident that the monoamine, neuroendocrine, and neurotrophic systems are interrelated in important ways. For example, HPA and steroid abnormalities may contribute to suppression of transcription of the BDNF gene. Glucocorticoid receptors are found in high density in the hippocampus. Binding of these hippocampal glucocorticoid receptors by cortisol during chronic stress states such as major depression may decrease BDNF synthesis and may result in volume loss in stress-sensitive regions such as the hippocampus. The chronic activation of monoamine receptors by antidepressants appears to have the opposite effect of stress and results in an increase in BDNF transcription. In addition, activation of monoamine receptors appears to down-regulate the HPA axis and may normalize HPA function."
        },
        {
            "id": "Physiology_Levy_4117",
            "title": "Physiology_Levy",
            "content": "recruitment of coactivator proteins and assembly of general transcription factors leading to increased or decreased transcription of the targeted genes. In some cases the GR interacts with other transcription factors, such as the proinflammatory nuclear factor (NF)\u03baB transcription factor, and interferes with their ability to activate gene expression. Physiological Actions of Cortisol"
        },
        {
            "id": "InternalMed_Harrison_26940",
            "title": "InternalMed_Harrison",
            "content": "import into the mitochondrion; and (3) increases the availability and phosphorylation of CREB (cAMP response element binding), a transcription factor that enhances transcription of CYP11A1 and other enzymes required for glucocorticoid synthesis."
        },
        {
            "id": "Surgery_Schwartz_241",
            "title": "Surgery_Schwartz",
            "content": "fasciculate of the adrenal glands to synthesize and secrete glucocorticoids (Fig. 2-3). Cortisol is the major glucocorticoid in humans and is essential for survival during significant physiologic stress. The resulting increase in cortisol levels following trauma have several important anti-inflammatory actions.Cortisol elicits its many actions through a cytosolic recep-tor, the glucocorticoid receptor (GR). Because it is lipid soluble, cortisol can diffuse through the plasma membrane to interact with its receptor, which is sequestered in the cytoplasm in a com-plex with heat shock proteins (Fig. 2-4). Upon ligand binding, the GR is activated and can employ a number of mechanisms to modulate proinflammatory gene transcription and signaling events, with a \u201cnet\u201d anti-inflammatory effect.79 For example, the activated GR complex can interact with transcription factors to sequester them in the cytoplasm, promote their degradation, or inhibit them through other mechanisms. Affected target"
        },
        {
            "id": "Pharmacology_Katzung_4356",
            "title": "Pharmacology_Katzung",
            "content": "region of the gene, and regulate transcription by RNA polymerase II and associated transcription factors. A variety of regulatory factors (not shown) may participate in facilitating (coactivators) or inhibiting (corepressors) the steroid response. The resulting mRNA is edited and exported to the cytoplasm for the production of protein that brings about the final hormone response. An alternative to the steroid-receptor complex interaction with a GRE is an interaction with and altering the function of other transcription factors, such as NF-\u03baB in the nucleus of cells."
        },
        {
            "id": "Cell_Biology_Alberts_1772",
            "title": "Cell_Biology_Alberts",
            "content": "Other cell types respond to glucocorticoids differently. Fat cells, for example, reduce the production of tyrosine aminotransferase, while some other cell types do not respond to glucocorticoids at all. These examples illustrate a general feature of cell specialization: different cell types often respond very differently to the same extracellular signal. Other features of the gene expression pattern do not change and give each cell type its permanently distinctive character. Gene expression Can Be regulated at Many of the Steps in the pathway from DnA to rnA to protein"
        },
        {
            "id": "Pharmacology_Katzung_4443",
            "title": "Pharmacology_Katzung",
            "content": "Zannas AS, Chrousos GP. Glucocorticoid signaling drives epigenetic and transcription factors to induce key regulators of human parturition. Sci Signal 2015;8:fs19. The patient should be placed on replacement oral hydrocor-tisone at 10 mg/m2 per day and fludrocortisone at 75 mcg/d. He should be given a MedicAlert bracelet and instructions for increased treatment at 2 times standard glucocorticoid dosage for 24 hours for minor stress and 10 times replace-ment of hydrocortisone for major stress over 48 hours. The Gonadal Hormones & Inhibitors George P. Chrousos, MD"
        }
    ],
    "scores": [
        0.039034527585906996,
        0.03814254649590611,
        0.03658064995909868,
        0.035972847455695484,
        0.035679717614383905,
        0.03469784986349224,
        0.034645808420679464,
        0.03399234186635761,
        0.03307366465561143,
        0.03250109736301597,
        0.03227393316066085,
        0.03144721227926569,
        0.03082848699135498,
        0.030729004813303224,
        0.030048910698878342,
        0.029396101313545704,
        0.028853268448163008,
        0.027987235703891562,
        0.02586719575092026,
        0.02539206802016898,
        0.02534159774650594,
        0.025278850278850275,
        0.02428447889642526,
        0.024103395825315666,
        0.023471697547520536,
        0.023239678067646992,
        0.023132448656209514,
        0.022817460317460316,
        0.022712051275722196,
        0.022515609325168072,
        0.02220849759910246,
        0.021874123300522776
    ]
}